Insonmina (Inc. chronic insomnia)
How it works:
Patients over the age of 18 years with insomnia (Inc. chronic insomnia).
Improving a patient’s insomnia symptoms.
Insomnia (Inc. Chronic Insomnia)
Target patient population:
Somzz is a type of digital therapeutics that can be applied to those over the age of 18 years to improve insomnia symptoms.
Somzz applies and implements the protocols of cognitive-behavioral therapy for insomnia (Stimulus Control Therapy, Sleep Restriction Therapy, Sleep Hygiene education, Relaxation Techniques, and Cognitive Therapy) through a mobile application.
This approach is considered the first-line recommended treatment for insomnia in clinical practice and Somzz provides education, real-time feedback, behavior intervention, and push notification message with a systematic algorithm to insomnia patients over 6 to 9 weeks.
What to expect:
More than half of the patients with chronic insomnia who participated in the clinical trial responded to “Somzz” with significant improvement in symptoms. In particular, 46.81% of the participants with insomnia symptoms showed remission at the end of the treatment program.
Indications for use:
Somzz is a Software as a Medical Device (SaMD) intended to improve insomnia symptoms by delivering a medical intervention (CBT-I) as a form of mobile application.
The clinical trial demonstrated that more than half of the patients showed treatment response with significant improvement in symptoms using Somzz. In particular, 46.81% of the patients reached remission at the end of the treatment program.
The patients used Somzz 2 to 3 times a day, for periods of 10–20 minutes. Somzz is used daily based on a planned and customized process for 6–9 weeks. The patients do daily assigned performances comprised of 6 treatment steps according to CBT-I, and a Sleep Diary completion followed by the recommended Time in Bed (TIB) based on the sleep restriction therapy.
Risks & warnings:
Somzz cannot be used if drowsiness due to sleep restrictions can cause serious accidents at the patient’s workplace or daily life. For patients with pathological conditions, it may also increase the risk for the pathophysiology to worsen. Thus, patients with negative conditions or the disabilities listed below cannot use Somzz as well: parasomnia, epilepsy, individuals at high risk of falling, individuals with other unstable or degenerative diseases.
Place in therapy:
Replaces face-to-face CBT-I therapy for insomnia.
Somzz is a Software as a Medical Device(SaMD) that applies and implements the protocols of cognitive-behavioral therapy for insomnia (CBT-I) through a mobile application with a systematic algorithm and provides education, real-time feedback, behavior intervention, and push notifications to insomnia patients over 6 to 9 weeks.
A prescription from a qualified healthcare provider is required.
The patients get the APK link from medical staff and install Somzz on their Android phones or tablets. After, the patients need to sign up and proceed with the personal authentication process. Use of this product requires access to:
Healthcare providers may access the management web portal to prescribe procedures and monitor patients’ treatment progress through the generated health data.
In progress – more details to come
Somzz is available in:
The provided set of evidence represents a sample of conducted studies. For a comprehensive collection contact manufacturers directly.
Note: for more research, please visit